These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 11123327

  • 1. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
    Nardin EH, Calvo-Calle JM, Oliveira GA, Nussenzweig RS, Schneider M, Tiercy JM, Loutan L, Hochstrasser D, Rose K.
    J Immunol; 2001 Jan 01; 166(1):481-9. PubMed ID: 11123327
    [Abstract] [Full Text] [Related]

  • 2. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
    Nardin EH, Calvo-Calle JM, Oliveira GA, Clavijo P, Nussenzweig R, Simon R, Zeng W, Rose K.
    Vaccine; 1998 Apr 01; 16(6):590-600. PubMed ID: 9569470
    [Abstract] [Full Text] [Related]

  • 3. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH.
    J Immunol; 1997 Aug 01; 159(3):1362-73. PubMed ID: 9233633
    [Abstract] [Full Text] [Related]

  • 4. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM, Oliveira GA, Watta CO, Soverow J, Parra-Lopez C, Nardin EH.
    Infect Immun; 2006 Dec 01; 74(12):6929-39. PubMed ID: 17030584
    [Abstract] [Full Text] [Related]

  • 5. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites.
    Calvo-Calle JM, Oliveira GA, Nardin EH.
    J Immunol; 2005 Dec 01; 175(11):7575-85. PubMed ID: 16301667
    [Abstract] [Full Text] [Related]

  • 6. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E.
    Vaccine; 2013 Apr 08; 31(15):1898-904. PubMed ID: 23481177
    [Abstract] [Full Text] [Related]

  • 7. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A, Lyons K, Schmidt A, Boyd D, Oliveira GA, Siddique A, Nussenzweig R, Calvo-Calle JM, Nardin E.
    Infect Immun; 2002 Dec 08; 70(12):6860-70. PubMed ID: 12438363
    [Abstract] [Full Text] [Related]

  • 8. An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.
    Parra-López CA, Bernal-Estévez D, Yin L, Vargas LE, Pulido-Calixto C, Salazar LM, Calvo-Calle JM, Stern LJ.
    PLoS One; 2014 Dec 08; 9(7):e100639. PubMed ID: 24983460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL.
    J Exp Med; 1995 Nov 01; 182(5):1435-45. PubMed ID: 7595214
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.
    Shiratsuchi T, Rai U, Kaneko I, Zhang M, Iwanaga S, Yuda M, Tsuji M.
    Vaccine; 2017 Dec 15; 35(50):6990-7000. PubMed ID: 29089194
    [Abstract] [Full Text] [Related]

  • 18. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E, Munesinghe YD, Moreno A, Clavijo P, Calle MC, Edelman R, Davis J, Herrington D, Nussenzweig RS.
    Mem Inst Oswaldo Cruz; 1992 Dec 15; 87 Suppl 3():223-7. PubMed ID: 1364202
    [Abstract] [Full Text] [Related]

  • 19. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.
    López JA, Weilenman C, Audran R, Roggero MA, Bonelo A, Tiercy JM, Spertini F, Corradin G.
    Eur J Immunol; 2001 Jul 15; 31(7):1989-98. PubMed ID: 11449351
    [Abstract] [Full Text] [Related]

  • 20. Identification and Immune Assessment of T Cell Epitopes in Five Plasmodium falciparum Blood Stage Antigens to Facilitate Vaccine Candidate Selection and Optimization.
    Kotraiah V, Phares TW, Terry FE, Hindocha P, Silk SE, Nielsen CM, Moise L, Tucker KD, Ashfield R, Martin WD, De Groot AS, Draper SJ, Gutierrez GM, Noe AR.
    Front Immunol; 2021 Jul 15; 12():690348. PubMed ID: 34305923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.